BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37366268)

  • 21. Disparity in Outcomes for Adolescent and Young Adult Patients Diagnosed With Pediatric Solid Tumors Across 4 Decades.
    Chen I; Pasalic D; Fischer-Valuck B; Frangoul H; DeWees T; Shinohara ET; Perkins SM
    Am J Clin Oncol; 2018 May; 41(5):471-475. PubMed ID: 27841802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, treatment and survival of paediatric patients with bone sarcomas in Finland from 1991 to 2005.
    Serlo J; Tarkkanen M; Sampo M; Vettenranta K; Riikonen P; Helenius I
    Acta Paediatr; 2015 Jul; 104(7):738-45. PubMed ID: 25721807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical analysis of 51 cases with rare childhood soft tissue sarcomas].
    Cai MX; Pan C; Ye QD; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):917-922. PubMed ID: 27938592
    [No Abstract]   [Full Text] [Related]  

  • 24. Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years.
    Basse C; Italiano A; Penel N; Mir O; Chemin C; Toulmonde M; Duffaud F; Le Cesne A; Chevreau C; Maynou C; Anract P; Gouin F; Rios M; Firmin N; Kurtz JE; Kerbrat P; Piperno-Neumann S; Bertucci F; Rosset P; Isambert N; Bompas E; Dubray-Longeras P; Fiorenza F; Le Maignan C; Chaigneau L; Thyss A; Bouché O; Eymard JC; Delcambre Lair C; Adam J; Karanian M; Lebbé C; Dupré A; Meeus P; Brahmi M; Dufresne A; Ducimetière F; Ray-Coquard I; Blay JY
    Int J Cancer; 2019 Oct; 145(8):2135-2143. PubMed ID: 30924137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary sarcomas of the spine: population-based demographic and survival data in 107 spinal sarcomas over a 23-year period in Ontario, Canada.
    Oitment C; Bozzo A; Martin AR; Rienmuller A; Jentzsch T; Aoude A; Thornley P; Ghert M; Rampersaud R
    Spine J; 2021 Feb; 21(2):296-301. PubMed ID: 32949731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.
    Kuo C; Kent PM; Logan AD; Tamulonis KB; Dalton KL; Batus M; Fernandez K; Mcfall RE
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review.
    Connolly EA; Bhadri VA; Wake J; Ingley KM; Lewin J; Bae S; Wong DD; Long AP; Pryor D; Thompson SR; Strach MC; Grimison PS; Mahar A; Bonar F; Maclean F; Hong A
    Cancer Med; 2022 Apr; 11(8):1805-1816. PubMed ID: 35178869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired social functioning in adolescent and young adult sarcoma survivors: Prevalence and risk factors.
    Drabbe C; Coenraadts ES; van Houdt WJ; van de Sande MAJ; Bonenkamp JJ; de Haan JJ; Nin JWM; Verhoef C; van der Graaf WTA; Husson O
    Cancer; 2023 May; 129(9):1419-1431. PubMed ID: 36787112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience.
    Zaikova O; Sundby Hall K; Styring E; Eriksson M; Trovik CS; Bergh P; Bjerkehagen B; Skorpil M; Weedon-Fekjaer H; Bauer HC
    J Surg Oncol; 2015 Dec; 112(8):853-60. PubMed ID: 26482729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcoma.
    Allignet B; Waissi W; Geets X; Dufresne A; Brahmi M; Ray-Coquard I; Blay JY; Bouhamama A; Meeus P; Vaz G; Gouin F; Moncharmont C; Sunyach MP
    Radiother Oncol; 2022 Aug; 173():55-61. PubMed ID: 35640770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience.
    Letaief F; Khrouf S; Yahiaoui Y; Hamdi A; Gabsi A; Ayadi M; Mezlini A
    J Orthop Surg (Hong Kong); 2020; 28(3):2309499020974501. PubMed ID: 33283661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network.
    Bompas E; Martin V; Meniai F; Toulmonde M; Marec-Berard P; Claude L; Ducimetiere F; Chargari C; Minard-Colin V; Corradini N; Laurence V; Piperno-Neumann S; Defachelles AS; Bernier V; Italiano A; Orbach D; Blay JY; Gaspar N; Berlanga P
    Bull Cancer; 2021 Feb; 108(2):163-176. PubMed ID: 33455736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
    Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-radiation sarcomas. Clinical outcome of 52 Patients.
    Mavrogenis AF; Pala E; Guerra G; Ruggieri P
    J Surg Oncol; 2012 May; 105(6):570-6. PubMed ID: 22012601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EORTC SPECTA-AYA: A unique molecular profiling platform for adolescents and young adults with cancer in Europe.
    de Rojas T; Kasper B; Van der Graaf W; Pfister SM; Bielle F; Ribalta T; Shenjere P; Preusser M; Fröhling S; Golfinopoulos V; Morfouace M; McCabe MG
    Int J Cancer; 2020 Aug; 147(4):1180-1184. PubMed ID: 31465545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center.
    Eastman BM; Hippe DS; Wootton LS; Nyflot MJ; Thompson MJ; Pollack SM; Kim E; Spraker MB
    BMC Cancer; 2021 May; 21(1):620. PubMed ID: 34039294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas.
    Choi YB; Yi ES; Lee JW; Yoo KH; Sung KW; Koo HH
    J Korean Med Sci; 2016 Jul; 31(7):1055-62. PubMed ID: 27366002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center.
    Dyrop HB; Vedsted P; Safwat A; Maretty-Nielsen K; Hansen BH; Jørgensen PH; Baad-Hansen T; Keller J
    Acta Orthop; 2014 Dec; 85(6):657-62. PubMed ID: 25175662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.